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To determine the predominant staphylococcal cassette
chromosome (SCC) mec element in methicillin-resistant
Staphylococcus aureus, we typed 190 isolates from a hos-
pital in Taiwan. We found a shift from type IV to type III
SCCmec element during 1992–2003, perhaps caused by
selective pressure from indiscriminate use of antimicrobial
drugs. 
T
he high prevalence of methicillin-resistant Staphylo-
coccus aureus (MRSA), which accounts for as much
as 80% of all S. aureus isolates causing nosocomial infec-
tions in Taiwanese hospitals since 1998, has greatly affect-
ed infection control and medical treatment in Taiwan (1).
At National Taiwan University Hospital (NTUH), a 2,200-
bed major teaching hospital in northern Taiwan, MRSA
has become a common nosocomial pathogen since the
early 1990s. The annual number and incidence of nosoco-
mial MRSA infections, as well as the number of available
nonduplicate isolates for the past 12 years at NTUH, are
shown in the Figure. 
In a previous study, we used pulsed-field gel elec-
trophoresis typing of 140 randomly selected nosocomial
MRSAisolates and samples from our collection of nosoco-
mial isolates obtained from 1992 to 1996 to identify 3
major pulsotypes (A, B, and C) (2). Pulsotype A was pre-
dominant among all MRSAisolates in 1992 (accounting for
50%) and 1993 (52%), pulsotype B was predominant in
1994 (59%) and 1995 (49%), and pulsotype C was predom-
inant in 1996 (83%) (2). Pulsotype C remained the predom-
inant clone until 2003 (J.-T. Wang et al., unpub. data).
S. aureus acquires methicillin resistance through a
mobile staphylococcal cassette chromosome (SCC) that
contains the mecA gene complex (SCCmec) (3). Until now,
5 major types of SCCmec element have been characterized
and studied (3–5). However, longitudinal studies of
SCCmec elements in nosocomial MRSA isolates in a hos-
pital have seldom been reported (6). We analyzed SCCmec
elements in predominant nosocomial MRSA clones at
NTUH from 1992 through 2003. Because the predominant
MRSA clone at NTUH from 1996 through 2003 was pul-
sotype C, MRSA isolates obtained from 1997 through
2002 were not studied.
The Study
We analyzed all 140 MRSA isolates we obtained dur-
ing a previous study (2) and 50 other isolates selected from
our collection of nosocomial MRSA isolates obtained in
2003. Characteristics of these 190 isolates are shown in
Table 1. 
Pulsed-field gel electrophoresis patterns were inter-
preted according to procedures previously reported (7,8).
Thirty-four isolates belonged to pulsotype A, 49 to pulso-
type B, 69 to pulsotype C, 6 to pulsotype D, 2 to pulsotype
E, 3 to pulsotype F, 11 to pulsotype K, 5 to pulsotype L, 8
to pulsotype M, and 3 (all isolated in 2003) to 3 minor pul-
sotypes. All isolates were tested by SCCmec element typ-
ing and multilocus sequence typing (MLST) (9) and were
analyzed for the Panton-Valentine leukocidin (PVL) gene
(10) and drug susceptibility to erythromycin, clindamycin,
gentamicin, amikacin, ciprofloxacin, levofloxacin, tetracy-
cline, trimethoprim-sulfamethoxazole, rifampin, and van-
comycin by using the disk diffusion method (11). SCCmec
element typing was determined by previously described
PCR methods (3–5).
Results of these analyses are shown in Table 2. MRSA
isolates of the same pulsotype have the same MLST pat-
tern and SCCmec types. Isolates with pulsotype A are
sequence type 254 (ST254); those with pulsotype B are
ST241; those with pulsotypes C, K, and L are ST239; and
those with pulsotypes D, E, F, and M are ST59, ST 254,
ST30, and ST5, respectively. All MRSA isolates with pul-
sotypes A, D, E, and F have the type IV SCCmec element.
However, only isolates with pulsotypes D and F, as well as
2 isolates from 2003 with 2 minor pulsotypes, have the
PVL gene. Isolates with pulsotypes B and C have the type
III SCCmec element, and isolates with pulsotype M have
the type II SCCmec element.
Results of MLST and typing of SCCmec elements of
the 3 isolates with 3 minor pulsotypes obtained in 2003 are
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Figure. Number and cumulative incidence of nosocomial methi-
cillin-resistant  Staphylococcus aureus (MRSA) infections per
1,000 discharges and number of available nonduplicate MRSA
isolates at National Taiwan University Hospital, 1992–2003.shown in Table 2. The correlation between SCCmec ele-
ment typing and MLST in this study corresponds to find-
ings of previous reports (6,12–14). Enright et al. identified
ST254-IV MRSA isolates in Germany and the United
Kingdom (12), and Chongtrakool et al. identified ST239-
III and ST241-III MRSA isolates in several Asian coun-
tries (14).
Conclusions
We demonstrate that the predominant MRSA clone at
NTUH in early 1990s had the type IV SCCmec element.
However, the predominant MRSA clones at NTUH from
1994 to 2003 had the type III SCCmec element. These
findings differ from those of Wisplinghoff et al., who
reported that that the SCCmec element in predominant
MRSA clones at their institute changed from type III in
1984 to 1988 to type I in 1989 to 1998 (6). Differences
between our findings and those of Wisplinghoff et al.
might be caused by differences in location and epidemio-
logic characteristics. 
MRSAisolates of pulsotypes B and C are more resist-
ant than isolates of pulsotype A to certain antimicrobial
drugs, especially fluoroquinolones and trimethoprim-sul-
famethoxazole; MRSA isolates with pulsotype C are more
resistant to clindamycin but less resistant to rifampin than
those with pulsotype B (Table 2). From 1993 through
2000, annual use of fluoroquinolones increased ≈3× at
NTUH; however, use of trimethoprim-sulfamethoxazole,
clindamycin, and rifampin did not change (15). Therefore,
the shift of predominant MRSA clones, which also led to
the shift in types of SCCmec elements at NTUH, might be
caused by selective pressure from antimicrobial drugs,
especially fluoroquinolones.
The MRSA clone (pulsotype A) that predominated in
1992 and 1993 at NTUH has the type IV SCCmec element.
Although the first study of MRSA with the type IV
SCCmec element reported that this element was found in
community-acquired MRSA (CA-MRSA) (5), some stud-
ies have reported MRSA isolates with this element in a
hospital environment (12). However, to our knowledge,
these reports did not demonstrate that MRSA isolates with
the type IV SCCmec element became predominant among
all MRSA isolates in an institution, especially before the
mid-1990s.
Furthermore, 4 ST59 MRSAisolates obtained in 1994
and 1996 and 3 ST30 MRSAisolates obtained in 1992 and
1993 have the type IV SCCmec element and PVL gene.
Recently, ST59 MRSA isolates were found to cause CA-
MRSA infection in Taiwan (13). Among these ST59 CA-
MRSA isolates, some had the type IV SCCmec element,
and others had the type V SCCmec element (13). Although
the type IV SCCmec element could be transferred to CA-
MRSA, Taiwan
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supports the possibility that ST59 MRSA isolates with the
SCCmec element type IV in Taiwan may originate from
hospital strains but transfer into CA-MRSA strains.
Chongtrakool et al. recently reported the results of
SCCmec typing of 615 MRSA isolates obtained in 1998
and 1999 from 11 Asian countries (14). The ST239-III,
ST241-III, ST254-II, and ST5-II MRSA isolates were
prevalent in many Asian countries. However, the ST254-
IV, ST30-IV, and ST59-IV MRSA isolates from our study
were not found in other Asian countries. In addition,
ST254-IV MRSA isolates have been found in Germany
and the United Kingdom (12). Whether ST254-IV MRSA
isolates in our study were transmitted from those in
Germany or the United Kingdom by international travel
requires further study.
The first MRSA isolate with the type IV SCCmec ele-
ment in our hospital appeared as early as 1992. The
SCCmec element carried by predominant MRSA clones
changed from type IV to type III SCCmec element during
the period 1992–2003 at NTUH. Because the major
MRSA clones isolated in 1994–2003 are more resistant to
antimicrobial drugs, especially fluoroquinolones and
trimethoprim-sulfamethoxazole, than those obtained in
1992 and 1993, this shift may be caused by selective pres-
sure from indiscriminate use of antimicrobial drugs.
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